Industries > Pharma > Pharma Wholesale and Distribution Market Forecasts 2018-2028

Pharma Wholesale and Distribution Market Forecasts 2018-2028

Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW

PUBLISHED: 06 November 2018
PAGES: 277
PRODUCT CODE: PHA0339

Clear
WOOCS 2.2.1

The pharma wholesale and distribution market is estimated to grow at a CAGR of 5.6% in the first half of the forecast period. The market is estimated to reach a revenue of $1.3bn in 2023. In 2017, the branded drugs submarket held 79% of the pharma wholesale and distribution market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 277-page report you will receive 93 tables and 107 figures– all unavailable elsewhere.

The 277-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Pharma Wholesale and Distribution Market from 2018-2028

• Forecast of the Global Pharma Wholesale and Distribution market by Category:
• Generic Drugs
• Branded Drugs
• Others

• This report provides individual revenue forecasts to 2028 for these national markets:
• US
• Germany
• France
• Italy
• Spain
• UK
• Japan
• China
• Brazil
• India
• Russia
• RoW

Pharma Wholesale and Distribution Market Forecasts 2018-2028

Each National Market is further segmented into generic drugs, branded drugs and others

• Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:
• Alfresa Holdings
• AmerisourceBergen
• Cardinal Health
• McKesson
• Medipal
• PHOENIX Group
• Shanghai Pharma
• SINOPHARM
• Suzuken
• Walgreens Boots Alliance

• This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.

Buy our report today Pharma Wholesale and Distribution Market Forecasts 2018-2028: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2018-2028


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories